ABCL - AbCellera expands its multi-tagret collaboration with Regeneron
2023-09-20 09:10:42 ET
More on AbCellera Biologics
- Seeking Alpha’s Quant Rating on AbCellera Biologics
- AbCellera Biologics: Promising Platform, But Watch-And-Wait Approach Advised
- AbCellera, Incyte partner for antibody-based cancer drugs
- Why did AbCellera Biologics stock dip today? AI-driven rally cools
For further details see:
AbCellera expands its multi-tagret collaboration with Regeneron